Fundraising Fox

Orisdx

Chicago, US · Founded 2022 · Delaware corporation · 2 known investors

orisdx.com ↗

OrisDX develops salivary diagnostics for early disease detection, starting with oral cancer. The company focuses on improving access to early detection through saliva-based testing.

BiotechDigital HealthMedical Devicesin /orisdx

Founders & leadership

HS
Harald SteltzerExecutive Officer, Director
EI
Evgeny IzmchenkoDirector
PC
Patrick ConniffExecutive Officer
NA
Nishant AgrawalDirector

Investors · 2

Angel Physicians Fund
HARPER COURT VENTURESChicagovia Karthee Madasamy · inferred

Reported raises · per SEC filings

Form D private placements
▶$2.8MraisedJul 2025 · 25 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Harald SteltzerExecutive Officer, Director
  • Evgeny IzmchenkoDirector
  • Patrick ConniffExecutive Officer
  • Nishant AgrawalDirector
Offering amount
$4M
Amount sold
$2.8M
First sale
May 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.